HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tesfaye Biftu Selected Research

Tesfaye Biftu Research Topics

Disease

6Type 2 Diabetes Mellitus (MODY)
01/2018 - 10/2005
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2022
1Glioma (Gliomas)
04/2022
1Myocardial Infarction
01/2022
1Peripheral Arterial Disease
01/2022
1Hyperinsulinism (Hyperinsulinemia)
01/2019
1Hyperglycemia
01/2019
1Metabolic Diseases (Metabolic Disease)
01/2019
1Weight Loss (Weight Reduction)
01/2018
1Hypoglycemia (Reactive Hypoglycemia)
01/2017
1Cardiomegaly (Heart Hypertrophy)
01/2017

Drug/Important Bio-Agent (IBA)

4Dipeptidyl-Peptidase IV InhibitorsIBA
04/2014 - 10/2005
2GlycogenIBA
01/2019 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2017
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
10/2013 - 10/2005
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2022
1vorapaxarIBA
01/2022
1LipidsIBA
01/2018
1Protein Kinases (Protein Kinase)IBA
01/2018
1EnzymesIBA
01/2018
1MK-8722IBA
01/2017
1Insulin (Novolin)FDA Link
01/2017
12- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
04/2014
11,4-diazepan-2-oneIBA
04/2007
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
10/2005